AquaBounty Technologies Inc

Análisis de la acción AquaBounty Technologies Inc (AQB)

$1.110

+0.010 (+0.91%)Al cierre

Loading chart…
Máximo
1.130
Apertura
1.100
Precio medio ponderado por volumen
1.10
Volumen
66.26K
Capitalización
6.40M
Mínimo
1.070
Importe
73.11K
EV/EBITDA, TTM
0.00

AquaBounty Technologies, Inc. is a land-based aquaculture company. The Company’s technology advances in fish breeding, genetics, and health and nutrition. It locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.

Análisis de IA of AquaBounty Technologies Inc (AQB)

Mantener

AquaBounty Technologies Inc (AQB) is currently not a strong buy due to its high RSI of 74.91, indicating it may be overbought, and its negative earnings per share (EPS) of -0.26 reported in the last quarter. Although the stock has shown a 5.71% increase over the past five days, it has a year-to-date change of +16.84%, which is positive, but the one-year change is down by 32.32%. The main risk is the company's ongoing negative net income, with a loss of -12,000,070 reported in Q1 2026. Therefore, while there are some positive short-term movements, the overall financial health and valuation metrics suggest caution before making a purchase.

Recomendaciones de analistas (1)

Comprar
1 Comprar
0 Mantener
0 Vender
Actual: 1.11
Mínimo
—
Promedio
—
Máximo
—

HC Wainwright & Co.

2024-05-16

Precio objetivo

—

Mantener

Oppenheimer

2024-04-02

Precio objetivo

—

Mantener

HC Wainwright & Co.

2023-11-08

Precio objetivo

—

Mantener

Oppenheimer

2023-10-20

Precio objetivo

—

Mantener

Oppenheimer

2023-08-02

Precio objetivo

$30

Comprar

Métricas de valoración

El PER previsto actual de AquaBounty Technologies Inc (AQB) es 0.00, frente a su media de 5 años de -1.91.

PER previsto

Valor razonable
Media 5A P/E
-1.91
P/E actual
0.00
Sobrevalorada
0.59
Infravalorada
-4.41

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
0.97
EV/EBITDA actual
0.00
Sobrevalorada
3.33
Infravalorada
-1.40

Precio/ventas previsto

Valor razonable
Media 5A P/S
10.75
P/S actual
4.36
Sobrevalorada
23.01
Infravalorada
-1.51

Escenarios de precio de Alphio AI para AQB

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%AQB

$0.69

Precio del escenario

B

Base

Base · 50%AQB

$0.57

Precio del escenario

B

Bajista

Bajista · 25%AQB

$0.44

Precio del escenario

Preguntas frecuentes sobre AQB, respondidas por Alphio AI

AquaBounty Technologies, Inc. is a land-based aquaculture company. The Company’s technology advances in fish breeding, genetics, and health and nutrition. It locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system. It operates in the Consumer Non-Cyclicals sector.

AquaBounty Technologies Inc (AQB) is currently not a strong buy due to its high RSI of 74.91, indicating it may be overbought, and its negative earnings per share (EPS) of -0.26 reported in the last quarter. Although the stock has shown a 5.71% increase over the past five days, it has a year-to-date change of +16.84%, which is positive, but the one-year change is down by 32.32%. The main risk is the company's ongoing negative net income, with a loss of -12,000,070 reported in Q1 2026. Therefore, while there are some positive short-term movements, the overall financial health and valuation metrics suggest caution before making a purchase.

1 analysts cover AQB: 1 rate it Buy, 0 Hold and 0 Sell.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar